Clot Burden Score and Early Ischemia Predict Intracranial Hemorrhage following Endovascular Therapy.
Journal
AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
23
11
2018
accepted:
11
02
2019
pubmed:
16
3
2019
medline:
17
3
2020
entrez:
16
3
2019
Statut:
ppublish
Résumé
Intracranial hemorrhage is a known complication following endovascular thrombectomy. The radiologic characteristics of a CT scan may assist with hemorrhage risk stratification. We assessed the radiologic predictors of intracranial hemorrhage following endovascular therapy using data from the INTERRSeCT (Identifying New Approaches to Optimize Thrombus Characterization for Predicting Early Recanalization and Reperfusion With IV Alteplase and Other Treatments Using Serial CT Angiography) study. Patients undergoing endovascular therapy underwent baseline imaging, postprocedural angiography, and 24-hour follow-up imaging. The primary outcome was any intracranial hemorrhage observed on follow-up imaging. The secondary outcome was symptomatic hemorrhage. We assessed the relationship between hemorrhage occurrence and baseline patient characteristics, clinical course, and imaging factors: baseline ASPECTS, thrombus location, residual flow grade, collateralization, and clot burden score. Multivariable logistic regression with backward selection was used to adjust for relevant covariates. Of the 199 enrolled patients who met the inclusion criteria, 46 (23%) had an intracranial hemorrhage at 24 hours. On multivariable analysis, postprocedural hemorrhage was associated with pretreatment ASPECTS (OR, 1.56 per point lost; 95% CI, 1.12-2.15), clot burden score (OR, 1.19 per point lost; 95% CI, 1.03-1.38), and ICA thrombus location (OR, 3.10; 95% CI, 1.07-8.91). In post hoc analysis, clot burden scores of ≤3 (sensitivity, 41%; specificity, 82%; OR, 3.12; 95% CI, 1.36-7.15) and pretreatment ASPECTS ≤ 7 (sensitivity, 48%; specificity, 82%; OR, 3.17; 95% CI, 1.35-7.45) robustly predicted hemorrhage. Residual flow grade and collateralization were not associated with hemorrhage occurrence. Symptomatic hemorrhage was observed in 4 patients. Radiologic factors, early ischemia on CT, and increased CTA clot burden are associated with an increased risk of intracranial hemorrhage in patients undergoing endovascular therapy.
Sections du résumé
BACKGROUND AND PURPOSE
Intracranial hemorrhage is a known complication following endovascular thrombectomy. The radiologic characteristics of a CT scan may assist with hemorrhage risk stratification. We assessed the radiologic predictors of intracranial hemorrhage following endovascular therapy using data from the INTERRSeCT (Identifying New Approaches to Optimize Thrombus Characterization for Predicting Early Recanalization and Reperfusion With IV Alteplase and Other Treatments Using Serial CT Angiography) study.
MATERIALS AND METHODS
Patients undergoing endovascular therapy underwent baseline imaging, postprocedural angiography, and 24-hour follow-up imaging. The primary outcome was any intracranial hemorrhage observed on follow-up imaging. The secondary outcome was symptomatic hemorrhage. We assessed the relationship between hemorrhage occurrence and baseline patient characteristics, clinical course, and imaging factors: baseline ASPECTS, thrombus location, residual flow grade, collateralization, and clot burden score. Multivariable logistic regression with backward selection was used to adjust for relevant covariates.
RESULTS
Of the 199 enrolled patients who met the inclusion criteria, 46 (23%) had an intracranial hemorrhage at 24 hours. On multivariable analysis, postprocedural hemorrhage was associated with pretreatment ASPECTS (OR, 1.56 per point lost; 95% CI, 1.12-2.15), clot burden score (OR, 1.19 per point lost; 95% CI, 1.03-1.38), and ICA thrombus location (OR, 3.10; 95% CI, 1.07-8.91). In post hoc analysis, clot burden scores of ≤3 (sensitivity, 41%; specificity, 82%; OR, 3.12; 95% CI, 1.36-7.15) and pretreatment ASPECTS ≤ 7 (sensitivity, 48%; specificity, 82%; OR, 3.17; 95% CI, 1.35-7.45) robustly predicted hemorrhage. Residual flow grade and collateralization were not associated with hemorrhage occurrence. Symptomatic hemorrhage was observed in 4 patients.
CONCLUSIONS
Radiologic factors, early ischemia on CT, and increased CTA clot burden are associated with an increased risk of intracranial hemorrhage in patients undergoing endovascular therapy.
Identifiants
pubmed: 30872416
pii: ajnr.A6009
doi: 10.3174/ajnr.A6009
pmc: PMC7048514
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
655-660Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© 2019 by American Journal of Neuroradiology.
Références
Stroke. 2017 Dec;48(12):e343-e361
pubmed: 29097489
Stroke. 2017 Oct;48(10):2912-2918
pubmed: 28887391
AJNR Am J Neuroradiol. 2009 Mar;30(3):525-31
pubmed: 19147716
AJNR Am J Neuroradiol. 2012 Jun;33(6):1088-94
pubmed: 22268092
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
Stroke. 2017 May;48(5):1299-1305
pubmed: 28389610
Stroke. 2017 Jul;48(7):1895-1900
pubmed: 28596447
JAMA. 2018 Sep 11;320(10):1017-1026
pubmed: 30208455
Diabetes Care. 2009 Apr;32(4):617-22
pubmed: 19131465
Int J Stroke. 2018 Jun;13(4):348-361
pubmed: 29171362
AJNR Am J Neuroradiol. 2012 Oct;33(9):1791-6
pubmed: 22538076
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
AJNR Am J Neuroradiol. 2014 Dec;35(12):2265-72
pubmed: 25059699
Neuroradiology. 2014 Sep;56(9):737-44
pubmed: 24925217
J Neurointerv Surg. 2019 Jul;11(7):625-629
pubmed: 30389897
Int J Stroke. 2008 Nov;3(4):230-6
pubmed: 18811738
Stroke. 2015 Oct;46(10):2981-6
pubmed: 26330447
Neuroradiology. 2013 Aug;55(8):977-987
pubmed: 23644538
Stroke. 2017 May;48(5):1203-1209
pubmed: 28373302
Stroke. 2006 Feb;37(2):556-61
pubmed: 16397182
J Stroke Cerebrovasc Dis. 2016 May;25(5):1076-1080
pubmed: 26923092
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
Lancet Neurol. 2018 Oct;17(10):895-904
pubmed: 30264728
J Neuroimaging. 2012 Apr;22(2):160-6
pubmed: 21143549
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Stroke. 2004 Feb;35(2):491-5
pubmed: 14739411
Stroke. 2015 May;46(5):1245-9
pubmed: 25828235
Stroke. 2017 Jul;48(7):1983-1985
pubmed: 28455322
J Neurointerv Surg. 2017 Apr;9(4):394-398
pubmed: 27036980
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Stroke. 2007 Jan;38(1):75-9
pubmed: 17122437